Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO) [NA]

View source ↗

Summary

This clinical trial update indicates that a study evaluating therapeutic drug monitoring of brodalumab in adults with plaque psoriasis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • brodalumab (brodalumab)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Psoriasis Vulgaris | NA | Status: RECRUITING